JPWO2020052677A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020052677A5
JPWO2020052677A5 JP2021514112A JP2021514112A JPWO2020052677A5 JP WO2020052677 A5 JPWO2020052677 A5 JP WO2020052677A5 JP 2021514112 A JP2021514112 A JP 2021514112A JP 2021514112 A JP2021514112 A JP 2021514112A JP WO2020052677 A5 JPWO2020052677 A5 JP WO2020052677A5
Authority
JP
Japan
Prior art keywords
peptide
hyp
lys
virus
tyr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021514112A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500437A (ja
JP7759693B2 (ja
JP2022500437A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/105832 external-priority patent/WO2020052677A1/en
Publication of JP2022500437A publication Critical patent/JP2022500437A/ja
Publication of JPWO2020052677A5 publication Critical patent/JPWO2020052677A5/ja
Publication of JP2022500437A5 publication Critical patent/JP2022500437A5/ja
Application granted granted Critical
Publication of JP7759693B2 publication Critical patent/JP7759693B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514112A 2018-09-14 2019-09-14 モンテルカストおよびペプチドの新規接合体 Active JP7759693B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2018/105703 2018-09-14
CN2018105703 2018-09-14
CNPCT/CN2018/119072 2018-12-04
CN2018119072 2018-12-04
PCT/CN2019/105832 WO2020052677A1 (en) 2018-09-14 2019-09-14 New conjugates of montelukast and peptides

Publications (4)

Publication Number Publication Date
JP2022500437A JP2022500437A (ja) 2022-01-04
JPWO2020052677A5 true JPWO2020052677A5 (https=) 2022-09-21
JP2022500437A5 JP2022500437A5 (https=) 2022-09-21
JP7759693B2 JP7759693B2 (ja) 2025-10-24

Family

ID=69777394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514112A Active JP7759693B2 (ja) 2018-09-14 2019-09-14 モンテルカストおよびペプチドの新規接合体

Country Status (27)

Country Link
US (2) US11680082B2 (https=)
EP (2) EP4253404A3 (https=)
JP (1) JP7759693B2 (https=)
KR (1) KR102946621B1 (https=)
CN (2) CN111601618A (https=)
AU (1) AU2019338582B2 (https=)
BR (1) BR112021004823A2 (https=)
CA (1) CA3112420A1 (https=)
DK (1) DK3678705T5 (https=)
ES (1) ES2956509T3 (https=)
FI (1) FI3678705T3 (https=)
HR (1) HRP20230946T1 (https=)
HU (1) HUE062848T2 (https=)
IL (1) IL281426A (https=)
LT (1) LT3678705T (https=)
MX (1) MX2021002657A (https=)
MY (1) MY205435A (https=)
PL (1) PL3678705T3 (https=)
PT (1) PT3678705T (https=)
RS (1) RS64436B1 (https=)
SA (1) SA521421448B1 (https=)
SG (1) SG11202102119RA (https=)
SI (1) SI3678705T1 (https=)
SM (1) SMT202300210T1 (https=)
TW (1) TWI875712B (https=)
WO (1) WO2020052677A1 (https=)
ZA (1) ZA202101398B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020000029A (es) * 2017-07-05 2020-08-06 Jiangyin Mucocare Pharmaceutical Co Ltd Formulaciones topicas que comprenden montelukast y combinaciones con proteinas adhesivas del mejillon.
MX2022003057A (es) * 2019-09-14 2022-06-16 Jiangyin Usun Pharmaceutical Co Ltd Nuevos peptidos.
CA3160167A1 (en) * 2019-12-02 2021-06-10 Ming Gu Peptides and their use in the treatment of inflammation
WO2021207606A1 (en) * 2020-04-10 2021-10-14 University Of Georgia Research Foundation, Inc. Methods for treatment of coronavirus infections
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102596264B1 (ko) * 2020-11-30 2023-11-01 주식회사 바이오빛 기능성 펩티드가 결합된 생체적합 폴리펩티드를 포함하는 염증 질환의 억제용 조성물
US20240165247A1 (en) * 2021-03-17 2024-05-23 Jiangyin Usun Pharmaceutical Co., Ltd. New peptide conjugates
WO2022193186A1 (en) * 2021-03-17 2022-09-22 Jiangyin Usun Pharmaceutical Co., Ltd. New diagnostic and therapeutic agents
WO2023225107A1 (en) * 2022-05-17 2023-11-23 Emory University Diroximel fumarate, inhalation administration methods, pharmaceutical uses and compositions
EP4665372A1 (en) * 2023-02-13 2025-12-24 EnliTISA (Shanghai) Pharmaceutical Co., Ltd. New multi-functional oligopeptides
WO2024260465A1 (en) * 2023-06-22 2024-12-26 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New multi-functional oligopeptides
TW202535906A (zh) * 2023-10-23 2025-09-16 大陸商安利提沙（上海）製藥有限公司 新型短鏈肽及其衍生物
KR20250075990A (ko) * 2023-11-22 2025-05-29 한도숙 상처 치료 또는 피부 주름형성 억제용 조성물
WO2025195444A1 (en) 2024-03-20 2025-09-25 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New use of peptides derived from vasoactive intestinal peptide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6669951B2 (en) 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
WO2003020200A2 (en) * 2000-11-16 2003-03-13 New River Pharmaceuticals Inc. A novel pharmaceutical compound and methods of making and using same
EP2316468A1 (en) * 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
PL374646A1 (en) 2002-07-08 2005-10-31 Pliva-Istrazivacki Institutt D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
US20050107612A1 (en) 2002-12-30 2005-05-19 Dr. Reddy's Laboratories Limited Process for preparation of montelukast and its salts
CA2522007A1 (en) * 2003-04-11 2004-10-28 Medimmune, Inc. Methods of preventing or treating respiratory conditions
JP4764818B2 (ja) * 2003-04-11 2011-09-07 メディミューン，エルエルシー 組換えｉｌ−９抗体およびその使用
CN101123878A (zh) 2003-07-29 2008-02-13 信号研发控股有限责任公司 氨基酸前药
US8173840B2 (en) 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
ES2337915T3 (es) 2004-10-27 2010-04-30 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugados con adtividad antiinflamatoria.
TW200740441A (en) * 2005-06-17 2007-11-01 Combinatorx Inc Methods and reagents for the treatment of inflammatory disorders
CA2773737C (en) * 2009-09-09 2021-11-16 Pharmain Corporation Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
CN102068432A (zh) 2011-01-11 2011-05-25 李仲昆 一种由他定类和白三烯拮抗剂组成的外用复方组合物
WO2012112690A2 (en) * 2011-02-16 2012-08-23 Fabius Biotechnology Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains
CN116898848A (zh) 2012-01-18 2023-10-20 苏州泰飞尔医药有限公司 治疗肺部疾病的高穿透力前药组合物和医药组合物
WO2014164285A2 (en) * 2013-03-13 2014-10-09 Inflammatory Response Research, Inc. Use of levocetirizine and montelukast in the treatment of vasculitis
US20160060328A1 (en) * 2013-10-25 2016-03-03 Lpath, Inc. Compositions and methods for binding cysteinyl leukotrienes (cyslts) for treatment of disease
WO2016044095A1 (en) * 2014-09-15 2016-03-24 Inflammatory Response Research, Inc. Levocetirizine and montelukast in the treatment of inflammation mediated conditions
KR102468519B1 (ko) * 2015-07-20 2022-11-21 장인 벵트 아이. 사무엘손 인스티튜트 오브 라이프 사이언스 컴퍼니 리미티드 피부 염증의 억제에서의 홍합 접착 단백질 제품 및 이의 적용
BR112019024563A2 (pt) 2017-05-24 2020-06-23 Transfert Plus S.E.C. Compostos peptídicos, compostos conjugados e usos dos mesmos para tratar doenças inflamatórias
JP7198785B2 (ja) * 2017-07-05 2023-01-04 ジャンイン ユスン ファーマシューティカル カンパニー，リミテッド ペプチドの抗炎症的使用
MX2020000029A (es) * 2017-07-05 2020-08-06 Jiangyin Mucocare Pharmaceutical Co Ltd Formulaciones topicas que comprenden montelukast y combinaciones con proteinas adhesivas del mejillon.

Similar Documents

Publication Publication Date Title
JP2022500437A5 (https=)
FI3678705T3 (fi) Montelukastin ja peptidien konjugaatteja
JPWO2020052677A5 (https=)
RU2455021C2 (ru) Композиции легочных сурфактантов и способы их применения, содействующие очищению от слизи
JP2026000993A (ja) 新ペプチド
JP2021525242A5 (https=)
CN113272298B (zh) 用于治疗呼吸系统疾病的化合物和组合物
WO2023169557A1 (zh) 一种次黄碱衍化合物在制备治疗肺纤维化药物中的应用
US20110166149A1 (en) Pteridine derivatives for treating respiratory disease
WO2021110061A1 (en) Peptides and their use in the treatment of inflammation
WO2023281063A1 (en) Broad-spectrum antiviral drugs
ES3049333T3 (en) Compounds for the treatment of respiratory diseases
RU2021105972A (ru) Новые конъюгаты монтелукаста и пептидов
CN119156396A (zh) 用于治疗covid感染的方法和组合物
JPWO2021110061A5 (https=)
US12612430B2 (en) Peptides
MD3678705T2 (ro) Conjugați de montelukast și peptide
WO2026077292A1 (zh) 一种天然衍生物在制备治疗非酒精性脂肪性肝病和/或肝纤维化药物中的应用
US7173009B2 (en) Surfactant protein C esters
JP2026067913A (ja) 新規なペプチドと多糖類とのコンジュゲート
HK40033390B (en) Conjugates of montelukast and peptides
JPWO2023146892A5 (https=)